News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Antisoma PLC (ASM.L) to Present at Piper Jaffray Health Care Conference on Tuesday, November 30


11/24/2010 9:31:57 AM

LONDON and CAMBRIDGE, MA--(Marketwire - November 24, 2010) - Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive Officer, Glyn Edwards, will present at the Piper Jaffray 22nd Annual Health Care Conference in New York City, on Tuesday, November 30th at 1.30 pm EST/ 6.30 pm GMT.

An audio webcast will be available on Antisoma's website at http://www.antisoma.com

To access the webcast live, please log on 15 minutes early in order to register and download any necessary software.

Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit www.antisoma.com for further information about Antisoma.


[HUG#1465216]


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Antisoma plc via Thomson Reuters ONE


Enquiries
Alison Saville
Marketing and Communications Manager
Antisoma plc
+44 (0) 20 3249 2100


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES